StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
MEDS

DataMEDS AI, Inc.

MEDS Nasdaq Wholesale-Drugs, Proprietaries & Druggists' Sundries EDGAR ↗
$3.24
+0.08 +2.53%

Key statistics

from XBRL data in SEC filings
Market cap
$407M
Revenue (TTM)
$14.0M
Net income (TTM)
-$76.6M
EPS (TTM)
$-0.88
P/E ratio
Dividend yield
Free cash flow
Cash
$51.7K
Total assets
$30.1M
Gross margin
-49.5%
52-week range
$2.49 – $97.50

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 29, 2026 8-K Amended charter or bylaws; Other events Jul 21, 2026 8-K Delisting notice or listing-rule failure; Other events Jun 12, 2026 8-K/A Jun 3, 2026 8-K/A Jun 2, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 29, 2026 8-K Other events May 21, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws May 21, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 19, 2026 10-Q Quarter ended 2026-03-31 May 19, 2026 8-K Regulation FD disclosure May 19, 2026 8-K Other events May 18, 2026 8-K Entered a material agreement May 7, 2026 8-K/A Entered a material agreement May 4, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 24, 2026 8-K/A Entered a material agreement; Delisting notice or listing-rule failure; Unregistered sale of equity; Regulation FD disclosure Apr 21, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Apr 17, 2026 8-K Entered a material agreement; Other events Apr 9, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Apr 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 20, 2026 8-K Entered a material agreement; Regulation FD disclosure Mar 11, 2026 8-K Regulation FD disclosure Mar 9, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Feb 13, 2026 8-K Director or officer change; Regulation FD disclosure Feb 9, 2026 8-K Director or officer change Feb 5, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jan 20, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jan 8, 2026 8-K Regulation FD disclosure Dec 19, 2025 8-K Delisting notice or listing-rule failure Dec 16, 2025 8-K Regulation FD disclosure Dec 8, 2025 8-K Regulation FD disclosure Dec 5, 2025 8-K Entered a material agreement; Regulation FD disclosure Nov 26, 2025 8-K/A Entered a material agreement; Regulation FD disclosure Nov 26, 2025 8-K Entered a material agreement; Regulation FD disclosure Nov 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 20, 2025 10-Q Quarter ended 2025-09-30 Nov 19, 2025 8-K Changed accountants Nov 17, 2025 8-K Other events Oct 30, 2025 8-K Regulation FD disclosure Oct 27, 2025 8-K Regulation FD disclosure; Other events Oct 22, 2025